glp 1 drug market GLP-1 Antagonists Increase Plan Spend - What's Next GLP-1 Analogues Market Size to

GLP-1 RAs demonstrated a beneficial effect on weight loss as opposed to the weight gain seen with insulin

doi: (Of importance) This cross-sectional study provides direct evidence that GLP-1 receptor agonist use may be accompanied by reduced intake of protein and selected micronutrients

doi: 10.1016/j.diabet.2025.101641

For those considering medically supervised weight loss, Rivas Medical Weight Loss offers comprehensive plans and expert care to support your health journey

Obesity also increases the risk of cardiovascular disease, where 5 kg increases in weight in adults is associated with an 11% higher risk of death from cardiovascular disease (strokes, coronary heart disease, myocardial infarction etc)

10.1038/s42255-023-00812-z 98 OforiJ